Systemic immunosuppressive therapy (IST) may increase susceptibility to infections: data from the Pharmachild Registry indicate that both, methotrexate (MTX) and biologics including TNF-inhibitors (TNFi), increase the risk of infection in JIA patients (6). The gene discussed is TNF; the disease is infection.